Harnessing HIV-specific T cells to eliminate latent viral reservoirs

Mark A. Brockman, PhD
Associate Professor and Canada Research Chair, Simon Fraser University
Associate Scientist, BC Centre for Excellence in HIV/AIDS

Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025